Background: Maternal tobacco consumption (both active and passive) during pregnancy as a risk factor for congenital heart diseases in off-springs has been studied by some workers with a small number of subjects hence requires to be evaluated through a study with a significant size of cohort. The objective of the study was to find out the association between maternal tobacco consumption and the risk of CHDs among their off springs.Methods: This is a hospital based, comparative, cross sectional, observational study. 518 children with CHDs, confirmed by echocardiography were included as cases and 240 children without any obvious congenital anomaly matched for age and sex were taken as controls. The following clinical observations were collected through questionnaires in a predesigned Performa: maternal and paternal tobacco consumption during pregnancy; maternal medical, gestational and obstetric history; and other birth defects.Results: Children from case and control groups were comparable with respect to age and sex at the inclusion in the study. Out of the total 758 study participants, 73 children (14.01%) with CHDs had history of maternal tobacco consumption (active consumption) during pregnancy and 86 children (16.6%) with CHDs had history of paternal smoking habit (P value was highly significant).Conclusions: Tobacco consumption during pregnancy (both active and passive) confer an increased risk of CHDs in their off springs (p value <0.001).
Introduction: Urinary incontinence (UI) affects > 60% women. Its management is simple with the use of Kegel exercises. However, very few studies have been done in India about this problem and its solution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.